FeesSafety
Pluang+

Sixth Street Specialty Lending remains a HOLD with stable dividends and NAV, but valuation limits upside.

Analyst Insights
18 Nov 2026, 14:05 WIB
Seeking Alpha
View Source
Neutral
Sixth Street Specialty Lending remains a HOLD with stable dividends and NAV, but valuation limits upside.

Sixth Street Specialty Lending (TSLX) is maintained at a HOLD rating due to sound fundamentals and a stable net asset value (NAV). The company covers its reset dividend, with expected net investment income (NII) of $0.44–$0.46 per share over the next two quarters. Although TSLX trades above its historical NII multiple, the valuation is not compelling enough to recommend a buy at current prices. Key risks include a rise in rating 3 loans to 5% and leverage hitting its ceiling, with income recovery partly dependent on fees and joint venture dividends.

Sixth Street Specialty Lending is the subject of this update, with Pluang providing a snapshot of the Financials sector as of Nov 18, 2026 18:41 WIB. Among 142 priced Financials-sector US stocks on Pluang, 81 rose and 52 fell today. Notable movers include WULF at USD 12.26 with a 5.06% increase, GEMI at USD 2.14 rising 4.39%, and HUT at USD 55.92 up 3.61%.

More News

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
49 minutes ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
55 minutes ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse, a B2B automotive software marketplace founded by General Motors, Magna, and Wipro, was honored with a CES Innovation Award 2027 in the Enterprise Tech category. The platform uses AI and standardized technical data to help automakers and supp...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App